Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Nevro Corp    NVRO

NEVRO CORP (NVRO)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/17 10:02:01 pm
80.71 USD   +2.46%
11/06 NEVRO : Reports Third Quarter 2017 Financial Results
11/06 NEVRO : reports 3Q loss
10/23 NEVRO : to Report Operating Results for the Third Quarter 2017
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/13/2017 11/14/2017 11/15/2017 11/16/2017 11/17/2017 Date
75(c) 76.81(c) 76.67(c) 78.77(c) 80.71(c) Last
406 723 370 876 273 169 463 556 461 320 Volume
+0.31% +2.41% -0.18% +2.74% +2.46% Change
More quotes
Financials ($)
Sales 2017 319 M
EBIT 2017 -25,3 M
Net income 2017 -33,4 M
Finance 2017 12,7 M
Yield 2017 -
Sales 2018 403 M
EBIT 2018 4,09 M
Net income 2018 -8,44 M
Finance 2018 72,1 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 7,45x
EV / Sales2018 5,75x
Capitalization 2 391 M
More Financials
Company
Nevro Corp. engages in the development and manufacture of medical devices.The company develops and commercializes neuromodulation platform for the treatment of chronic pain.It offers a spinal cord stimulation system under the Senza, HF10, and Nevro brands.The company was founded in March 2006 and... 
More about the company
Surperformance© ratings of Nevro Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on NEVRO CORP
11/15 NEVRO : Neurostimulation implant Supplies
11/06 NEVRO : Reports Third Quarter 2017 Financial Results
11/06 NEVRO : Management's Discussion and Analysis of Financial Condition and Results ..
11/06 NEVRO : reports 3Q loss
11/06 NEVRO CORP : Results of Operations and Financial Condition, Financial Statements..
11/06 NEVRO CORP : Nevro Corp. to Host Earnings Call
10/23 NEVRO : to Report Operating Results for the Third Quarter 2017
09/14 RESEARCHERS FROM NEVRO CORPORATION D : An Assessment of Technical Factors Relate..
08/24 NEVRO : to Present at Upcoming Investor Conferences
08/18 NEVRO : Today's Research Report Coverage on Medical Equipment Stocks -- Avinger,..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
11/13 Poor earnings updates keep European shares at seven-week low
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/12 FISHER & PAYKEL HEALTHCARE : & Paykel says UK court rules rival Resmed's patent ..
11/03 ESSILOR INTERNATIONAL : EU regulators suspend Luxottica, Essilor probe, await da..
11/03DJESSILOR INTERNATIONAL : EU Regulator Has Suspended Essilor, Luxottica Probe -Reu..
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
11/06 Nevro's (NVRO) CEO Rami Elghandour on Q3 2017 Results - Earnings Call Transcr..
11/06 Nevro beats by $0.01, beats on revenue
11/05 Notable earnings after Monday?s close
10/11 YOUR DAILY PHARMA SCOOP : Alexion's Catalysts, Amgen's Prolia, Ultragenyx Borosu..
09/29 YOUR DAILY PHARMA SCOOP : Axovant's Promised Upside, Gilead's Whistleblower Trou..
Chart NEVRO CORP
Duration : Period :
Nevro Corp Technical Analysis Chart | NVRO | US64157F1030 | 4-Traders
Technical analysis trends NEVRO CORP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 104 $
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
Rami Elghandour President, Chief Executive Officer & Director
Michael F. DeMane Chairman
Patrick Schmitz Vice President-Operations
Andrew H. Galligan Chief Financial Officer
Bradford E. Gliner Vice President-Clinical & Regulatory
Sector and Competitors
1st jan.Capitalization (M$)
NEVRO CORP11.08%2 391
MEDTRONIC PLC11.60%107 676
BAXTER INTERNATIONAL44.07%34 804
C R BARD INC48.47%24 314
ZIMMER BIOMET HOLDINGS INC8.15%22 598
ALIGN TECHNOLOGY164.11%20 356